EGFR and malignant colon neoplasm: Fibroblast growth factor 9 (FGF9) plays a critical role in patients with colon cancer with resistance to epidermal growth factor receptor (EGFR)-targeted therapy, and combination therapy with anti-EGFR inhibitor may reverse drug resistance [21].